Editor’s note: This response was edited lightly for clarity and brevity.
Question: How would you grade (A-F) CMS’ performance in 2022?
Dennis Fliegelman: As to CMS, they play politics, so a ‘C’ is all they can garner, e.g. rate change. The authorization delays and denials have been a growing concern that just recently came to the forefront, yet CMS keeps pushing Medicare Advantage plans run by the same commercial payers that are earning record profits by denying legitimate authorizations and care. I also question CMS’ methodology to determine what procedures get approval for outpatient reimbursement.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.